Name: COLL Debt Components
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#dissemination

Collegium Pharmaceutical, Inc. (COLL) Debt Components

2024-04-11: Long-term Debt, GrossUSD $26.35M; Debt, CurrentUSD (m); Long-term DebtUSD (m); Long-Term Debt, Maturity, Year OneUSD (m).
2023-09-30: Long-term Debt, GrossUSD (m); Debt, CurrentUSD (m); Long-term DebtUSD (m); Long-Term Debt, Maturity, Year OneUSD (m).
2023-06-30: Long-term Debt, GrossUSD (m); Debt, CurrentUSD (m); Long-term DebtUSD (m); Long-Term Debt, Maturity, Year OneUSD (m).
2023-03-31: Long-term Debt, GrossUSD (m); Debt, CurrentUSD (m); Long-term DebtUSD (m); Long-Term Debt, Maturity, Year OneUSD (m).

Collegium Pharmaceutical, Inc. Debt Components

Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.

Period end	Long-term Debt, Gross USD	Debt, Current USD	Long-term Debt USD	Long-Term Debt, Maturity, Year One USD	Long-Term Debt, Maturity, Year Two USD	Long-Term Debt, Maturity, Year Three USD	Long-Term Debt, Maturity, Year Four USD	Line of Credit Facility, Maximum Borrowing Capacity USD	Line of Credit Facility, Periodic Payment USD	Debt, Long-term and Short-term, Combined Amount USD	Debt Instrument, Fair Value Disclosure USD	Debt Instrument, Convertible, Carrying Amount of Equity Component USD	Notes Payable, Related Parties, Current USD
2024-04-11	$26.35M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2023-09-30	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	$458.33M	(m)	(m)
2023-06-30	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	$504.17M	(m)	(m)
2023-03-31	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	$550.00M	(m)	(m)
2022-09-30	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	$600.00M	(m)	(m)
2022-06-30	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	$625.00M	(m)	(m)
2022-03-31	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	$650.00M	(m)	(m)
2020-12-31	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	$46.55M	(m)
2019-12-31	(m)	(m)	$11.50M	$3.83M	$3.83M	$3.83M	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2019-09-30	(m)	(m)	$11.50M	(m)	$3.83M	$3.83M	$3.83M	(m)	(m)	(m)	(m)	(m)	(m)
2019-06-30	(m)	(m)	$11.50M	(m)	$3.83M	$3.83M	$3.83M	(m)	(m)	(m)	(m)	(m)	(m)
2019-03-31	(m)	(m)	$11.50M	$1.64M	$3.29M	$3.29M	$3.29M	(m)	(m)	(m)	(m)	(m)	(m)
2018-12-31	(m)	(m)	$11.50M	$1.64M	$3.29M	$3.29M	$3.29M	(m)	(m)	(m)	(m)	(m)	(m)
2018-09-30	(m)	(m)	$11.50M	$1.64M	$3.29M	$3.29M	$3.29M	(m)	(m)	(m)	(m)	(m)	(m)
2018-06-30	(m)	(m)	$11.50M	$1.64M	$3.29M	$3.29M	$3.29M	(m)	(m)	(m)	(m)	(m)	(m)
2018-03-31	(m)	(m)	$11.50M	$1.64M	$3.29M	$3.29M	$3.29M	(m)	(m)	(m)	(m)	(m)	(m)
2017-12-31	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	$1.48M	(m)	(m)	(m)	(m)
2017-12-31	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	12 month · $1.48M	(m)	(m)	(m)	(m)
2017-12-31	(m)	(m)	(m)	$1.48M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2016-12-31	(m)	(m)	$4.15M	$2.67M	$1.48M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2015-12-31	(m)	$2.67M	(m)	(m)	$2.67M	$1.48M	(m)	(m)	(m)	$6.81M	(m)	(m)	(m)
2014-12-31	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	$5.00M
2012-08-28	(m)	(m)	(m)	(m)	(m)	(m)	(m)	$1.00M	(m)	(m)	(m)	(m)	(m)
2012-08-12	(m)	(m)	(m)	(m)	(m)	(m)	(m)	$1.00M	(m)	(m)	(m)	(m)	(m)

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Faeth Therapeutics, Inc. (FTH)	United States	$0.750B
Design Therapeutics, Inc. (DSGN)	United States	$0.766B	-12.78
Verastem, Inc. (VSTM)	United States	$0.706B	-1.71
Nuvectis Pharma, Inc. (NVCT)	United States	$0.705B	-17.53
IRONWOOD PHARMACEUTICALS INC (IRWD)	United States	$0.694B	5.37
Wave Life Sciences, Inc. (WVE)		$0.780B	-5.56
Olema Pharmaceuticals, Inc. (OLMA)	United States	$0.790B	-5.35
Climb Bio, Inc. (CLYM)	United States	$0.683B	-13.03
Aclaris Therapeutics, Inc. (ACRS)	United States	$0.792B	-9.78
GERON CORP (GERN)	United States	$0.803B	-12.14